VR Logo

Cytek Biosciences Inc. (CTKB) download report


Healthcare | Medical Devices & Equipment

Cytek Biosciences Inc. (CTKB) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

IPO Date: 23-Jul-2021

Pres, CEO & Chairman: Dr. Wenbin Jiang Ph.D.

Chief Financial Officer: Mr. Patrik Sebastian Jeanmonod

Listing: NASDAQ: CTKB

Country: United States

Headquarters: Fremont, CA

Website: https://cytekbio.com

Key Facts

Market cap: $1,472.07 Mln

Revenue (TTM): $73.96 Mln

Earnings (TTM): $1.19 Mln

Cash: $362.51 Mln

Total Debt: $14.90 Mln

Insider's Holding: 17.46%

Liquidity: Low

52 Week range: $7.39 - 28.70

Shares outstanding: 134,312,992

Stock Performance

Time Period Cytek Biosciences (CTKB) S&P BSE Sensex* S&P Small-Cap 600*
YTD-32.84-8.62-18.78
1 month8.51-4.54-8.00
3 months1.67-10.19-13.65
1 Year--1.43-17.19
3 Years--10.146.10
5 Years--11.265.87
10 Years--11.829.84
As on 01-Jul-2022 *As on 04-Jul-2022